Although approximately 30% of the enrolled subjects did not present detectable levels of both IgM and IgG after the first symptomatic infection, the protective role of memory B cells against COVID-19 recurrence could not be excluded since these cells can be activated without the presence of detectable levels of immunoglobulins. This evidence concerns the gene CD40LG and COVID-19.